Denervation suppresses gastric tumorigenesis

Science Translational Medicine

Volumn 6, Issue 250, 2014, Pages

  Zhao, Chun Mei ^a   Hayakawa, Yoku ^b   Kodama, Yosuke ^a   Muthupalani, Sureshkumar ^c   Westphalen, Christoph B ^b,d   Andersen, Gøran T ^a,e   Flatberg, Arnar ^a   Johannessen, Helene ^a   Friedman, Richard A ^b   Renz, Bernhard W ^b   Sandvik, Arne K ^a,e   Beisvag, Vidar ^a   Tomita, Hiroyuki ^f   Hara, Akira ^f   Quante, Michael ^g   Li, Zhishan ^b   Gershon, Michael D ^b   Kaneko, Kazuhiro ^h   Fox, James G ^c   Wang, Timothy C ^b   Chen, Duan ^a   more..

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b Columbia University College of Physicians and Surgeons ^*  (United States)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^d LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^e TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^f GIFU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^g TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^h NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A; FLUOROURACIL; MUSCARINIC M3 RECEPTOR; OXALIPLATIN; WNT PROTEIN; PERIPHERIN; TUMOR MARKER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER INCIDENCE; CANCER STAGING; CANCER SURVIVAL; CARCINOGENESIS; CELL EXPANSION; DRUG EFFICACY; GASTRIC TUMORIGENESIS; HUMAN; METASTASIS INHIBITION; MOUSE; NONHUMAN; PHARMACOLOGICAL BLOCKING; SIGNAL TRANSDUCTION; STEM CELL; STOMACH CANCER; SURVIVAL TIME; VAGOTOMY; ANIMAL; CANCER STEM CELL; CELL PROLIFERATION; DENERVATION; DISEASE COURSE; DISEASE MODEL; INFLAMMATION; METABOLISM; NERVE CELL; PATHOLOGY; STOMACH NEOPLASMS; WNT SIGNALING PATHWAY;

ANIMALS; BIOMARKERS, TUMOR; CARCINOGENESIS; CELL PROLIFERATION; DENERVATION; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; INFLAMMATION; MICE; NEOPLASTIC STEM CELLS; NEURONS; PERIPHERINS; RECEPTOR, MUSCARINIC M3; STOMACH NEOPLASMS; WNT SIGNALING PATHWAY;

EID: 84907395110     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.3009569     Document Type: Article

References (54)

1. Y. Katayama, M. Battista, W. M. Kao, A. Hidalgo, A. J. Peired, S. A. Thomas, P. S. Frenette, Signals from the sympathetic nervous system regulate hematopoietic stem cell egress from bone marrow. Cell 124, 407-421 (2006).
2. O. Lundgren, M. Jodal, M. Jansson, A. T. Ryberg, L. Svensson, Intestinal epithelial stem/progenitor cells are controlled by mucosal afferent nerves. PLOS One 6, e16295 (2011).
3. R. R. Mattingly, A. Sorisky, M. R. Brann, I. G. Macara, Muscarinic receptors transform NIH 3T3 cells through a Ras-dependent signalling pathway inhibited by the Ras-GTPase-activating protein SH3 domain. Mol. Cell. Biol. 14, 7943-7952 (1994).
4. G. E. Ayala, H. Dai, M. Powell, R. Li, Y. Ding, T. M. Wheeler, D. Shine, D. Kadmon, T. Thompson, B. J. Miles, M. M. Ittmann, D. Rowley, Cancer-related axonogenesis and neurogenesis in prostate cancer. Clin. Cancer Res. 14, 7593-7603 (2008).
5. N. Shah, S. Khurana, K. Cheng, J. P. Raufman, Muscarinic receptors and ligands in cancer. Am. J. Physiol. Cell Physiol. 296, C221-C232 (2009).
6. min/+mice. Carcinogenesis 32, 1396-1402 (2011).
7. C. Magnon, S. J. Hall, J. Lin, X. Xue, L. Gerber, S. J. Freedland, P. S. Frenette, Autonomic nerve development contributes to prostate cancer progression. Science 341, 1236361 (2013).
8. R. Pardal, M. F. Clarke, S. J. Morrison, Applying the principles of stem-cell biology to cancer. Nat. Rev. Cancer 3, 895-902 (2003).
9. +vestem cells drive self-renewal in the stomach and build long-lived gastric units in vitro. Cell Stem Cell 6, 25-36 (2010).
10. J. Ferlay, H. R. Shin, F. Bray, D. Forman, C. Mathers, D. M. Parkin, Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int. J. Cancer 127, 2893-2917 (2010).
11. A. Jemal, M. M. Center, C. DeSantis, E. M. Ward, Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol. Biomarkers Prev. 19, 1893-1907 (2010).
12. R. Ha˚kanson, S. Vallgren, M. Ekelund, J. F. Rehfeld, F. Sundler, The vagus exerts trophic control of the stomach in the rat. Gastroenterology 86, 28-32 (1984).
13. J. Axelson, M. Ekelund, R. Ha˚kanson, F. Sundler, Gastrin and the vagus interact in the trophic control of the rat oxyntic mucosa. Regul. Pept. 22, 237-243 (1988).
14. G. Lundega˚rdh, A. Ekbom, J. K. McLaughlin, O. Nyrén, Gastric cancer risk after vagotomy. Gut 35, 946-949 (1994).
15. S. Bahmanyar, W. Ye, P. W. Dickman, O. Nyrén, Long-term risk of gastric cancer by subsite in operated and unoperated patients hospitalized for peptic ulcer. Am. J. Gastroenterol. 102, 1185-1191 (2007).
16. P. Correa, C. Cuello, E. Duque, Carcinoma and intestinal metaplasia of the stomach in Colombian migrants. J. Natl. Cancer Inst. 44, 297-306 (1970).
17. M. Cassaro, M. Rugge, O. Gutierrez, G. Leandro, D. Y. Graham, R. M. Genta, Topographic patterns of intestinal metaplasia and gastric cancer. Am. J. Gastroenterol. 95, 1431-1438 (2000).
18. T. C. Wang, C. A. Dangler, D. Chen, J. R. Goldenring, T. Koh, R. Raychowdhury, R. J. Coffey, S. Ito, A. Varro, G. J. Dockray, J. G. Fox, Synergistic interaction between hypergastrinemia and Helicobacter infection in a mouse model of gastric cancer. Gastroenterology 118, 36-47 (2000).
19. J. G. Fox, T. C. Wang, Inflammation, atrophy, and gastric cancer. J. Clin. Invest. 117, 60-69 (2007).
20. P. Ericsson, R. Ha˚kanson, J. F. Rehfeld, P. Norlén, Gastrin release: Antrum microdialysis reveals a complex neural control. Regul. Pept. 161, 22-32 (2010).
21. A. B. Rogers, N. S. Taylor, M. T. Whary, E. D. Stefanich, T. C. Wang, J. G. Fox, Helicobacter pylori but not high salt induces gastric intraepithelial neoplasia in B6129 mice. Cancer Res. 65, 10709-10715 (2005).
22. H. Tomita, S. Takaishi, T. R. Menheniott, X. Yang, W. Shibata, G. Jin, K. S. Betz, K. Kawakami, T. Minamoto, C. Tomasetto, M. C. Rio, N. Lerkowit, A. Varro, A. S. Giraud, T. C. Wang, Inhibition of gastric carcinogenesis by the hormone gastrin is mediated by suppression of TFF1 epigenetic silencing. Gastroenterology 140, 879-891 (2011).
23. S. Tu, G. Bhagat, G. Cui, S. Takaishi, E. A. Kurt-Jones, B. Rickman, K. S. Betz, M. Penz-Oesterreicher, O. Bjorkdahl, J. G. Fox, T. C. Wang, Overexpression of interleukin-1β induces gastric inflammation and cancer and mobilizes myeloid-derived suppressor cells in mice. Cancer Cell 14, 408-419 (2008).
24. D. Dressler, F. Adib Saberi, Botulinum toxin: Mechanisms of action. Eur. Neurol. 53, 3-9 (2005).
25. P. Polakis, Drugging Wnt signalling in cancer. EMBO J. 31, 2737-2746 (2012).
26. F. Takahashi-Yanaga, M. Kahn, Targeting Wnt signaling: Can we safely eradicate cancer stem cells? Clin. Cancer Res. 16, 3153-3162 (2010).
27. M. Zöller, CD44: Can a cancer-initiating cell profit from an abundantly expressed molecule? Nat. Rev. Cancer 11, 254-267 (2011).
28. S. Takaishi, T.Okumura, S. Tu, S. S. Wang, W. Shibata, R. Vigneshwaran, S. A. Gordon, Y. Shimada, T. C. Wang, Identification of gastric cancer stem cells using the cell surface marker CD44. Stem Cells 27, 1006-1020 (2009).
29. J. Schuijers, H. Clevers, Adult mammalian stem cells: The role of Wnt, Lgr5 and R-spondins. EMBO J. 31, 2685-2696 (2012).
30. J. Chen, Y. Li, T. S. Yu, R. M. McKay, D. K. Burns, S. G. Kernie, L. F. Parada, A restricted cell population propagates glioblastoma growth after chemotherapy. Nature 488, 522-526 (2012).
31. S. Okabe, Y. Kodama, H. Cao, H. Johannessen, C. M. Zhao, T. C. Wang, R. Takahashi, D. Chen, Topical application of acetic acid in cytoreduction of gastric cancer. A technical report using mouse model. J. Gastroenterol. Hepatol. 27 (Suppl. 3), 40-48 (2012).
32. P. Song, H. S. Sekhon, X. W. Fu, M. Maier, Y. Jia, J. Duan, B. J. Proskosil, C. Gravett, J. Lindstrom, G. P. Mark, S. Saha, E. R. Spindel, Activated cholinergic signaling provides a target in squamous cell lung carcinoma. Cancer Res. 68, 4693-4700 (2008).
33. C. B. Westphalen, S. Asfaha, Y. Hayakawa, Y. Takemoto, D. J. Lukin, A. H. Nuber, A. Brandtner, W. Setlik, H. Remotti, A. Muley, X. Chen, R. May, C. W. Houchen, J. G. Fox, M. D. Gershon, M. Quante, T. C. Wang, Long-lived intestinal tuft cells serve as colon cancer-initiating cells. J. Clin. Invest. 124, 1283-1295 (2014).
34. A. A. Gershon, J. Chen, M. D. Gershon, A model of lytic, latent, and reactivating varicella-zoster virus infections in isolated enteric neurons. J. Infect. Dis. 197 (Suppl. 2), S61-S65 (2008).
35. N. Barker, H. Clevers, Leucine-rich repeat-containing G-protein-coupled receptors as markers of adult stem cells. Gastroenterology 138, 1681-1696 (2010).
36. M. Tatsuta, H. Yamamura, H. Iishi, M. Ichii, S. Noguchi, M. Baba, H. Taniguchi, Promotion by vagotomy of gastric carcinogenesis induced by N-methyl-N′-nitro-N-nitrosoguanidine in Wistar rats. Cancer Res. 45, 194-197 (1985).
37. M. Tatsuta, H. Iishi, H. Yamamura, M. Baba, H. Taniguchi, Effects of bilateral and unilateral vagotomy on gastric carcinogenesis induced by N-methyl-N′-nitro-N-nitrosoguanidine in Wistar rats. Int. J. Cancer 42, 414-418 (1988).
38. P. S. Frenette, S. Pinho, D. Lucas, C. Scheiermann, Mesenchymal stem cell: Keystone of the hematopoietic stem cell niche and a stepping-stone for regenerative medicine. Annu. Rev. Immunol. 31, 285 -316 (2013).
39. E. R. Gross, M. D. Gershon, K. G. Margolis, Z. V. Gertsberg, R. A. Cowles, Neuronal serotonin regulates growth of the intestinal mucosa in mice. Gastroenterology 143, 408-417.e2 (2012).
40. T. Sato, J. H. van Es, H. J. Snippert, D. E. Stange, R. G. Vries, M. van den Born, N. Barker, N. F. Shroyer, M. van de Wetering, H. Clevers, Paneth cells constitute the niche for Lgr5 stem cells in intestinal crypts. Nature 469, 415-418 (2011).
41. D. W. Powell, I. V. Pinchuk, J. I. Saada, X. Chen, R. C. Mifflin, Mesenchymal cells of the intestinal lamina propria. Annu. Rev. Physiol. 73, 213-237 (2011).
42. H. F. Farin, J. H. Van Es, H. Clevers, Redundant sources of Wnt regulate intestinal stem cells and promote formation of Paneth cells. Gastroenterology 143, 1518-1529.e7 (2012).
43. D. Revesz, M. Tjernstrom, E. Ben-Menachem, T. Thorlin, Effects of vagus nerve stimulation on rat hippocampal progenitor proliferation. Exp. Neurol. 214, 259-265 (2008).
44. D. Cassiman, L. Libbrecht, N. Sinelli, V. Desmet, C. Denef, T. Roskams, The vagal nerve stimulates activation of the hepatic progenitor cell compartment via muscarinic acetylcholine receptor type 3. Am. J. Pathol. 161, 521-530 (2002).
45. 3muscarinic receptor knockout mice. Gastroenterology 125, 1774-1784 (2003).
46. S. Salmanian, S. M. Najafi, M. Rafipour, M. R. Arjomand, H. Shahheydari, S. Ansari, L. Kashkooli, S. J. Rasouli, M. S. Jazi, T. Minaei, Regulation of GSK-3β and β-catenin by Gαq in HEK293T cells. Biochem. Biophys. Res. Commun. 395, 577-582 (2010).
47. E. R. Spindel, Muscarinic receptor agonists and antagonists: Effects on cancer. Handb. Exp. Pharmacol. 451-468 (2012).
48. 3muscarinic receptors attenuates murine colon epithelial cell proliferation and neoplasia. Cancer Res. 68, 3573-3578 (2008).
49. P. W. Veenboer, J. L. Bosch, Long-term adherence to antimuscarinic therapy in everyday practice: A systematic review. J. Urol. 191, 1003-1008 (2014).
50. P. Song, H. S. Sekhon, A. Lu, J. Arredondo, D. Sauer, C. Gravett, G. P. Mark, S. A. Grando, E. R. Spindel, M3 muscarinic receptor antagonists inhibit small cell lung carcinoma growth and mitogen-activated protein kinase phosphorylation induced by acetylcholine secretion. Cancer Res. 67, 3936-3944 (2007).
51. 2induction. Pathol. Int. 60, 599-607 (2010).
52. J. H. van Es, P. Jay, A. Gregorieff, M. E. van Gijn, S. Jonkheer, P. Hatzis, A. Thiele, M. van den Born, H. Begthel, T. Brabletz, M. M. Taketo, H. Clevers, Wnt signalling induces maturation of Paneth cells in intestinal crypts. Nat. Cell Biol. 7, 381-386 (2005).
53. S. Fre, S. K. Pallavi, M. Huyghe, M. Laé, K. P. Janssen, S. Robine, S. Artavanis-Tsakonas, D. Louvard, Notch and Wnt signals cooperatively control cell proliferation and tumorigenesis in the intestine. Proc. Natl. Acad. Sci. U.S.A. 106, 6309-6314 (2009).
54. L. Lehtiö, N. W. Chi, S. Krauss, Tankyrases as drug targets. FEBS J. 280, 3576-3593 (2013).